Abstract

Ferric sulfate (Astringedent) and aluminum chloride (Hemodent) have been proposed as possible medicaments for use in primary teeth for therapeutic pulpotomies.

There is little information in the literature about the biologic properties of these medicaments.

The purpose of this study was to evaluate the mutagenic response of the ferric sulfate and aluminum chloride and compare them with glutaraldehyde (1.5%, 1% and 0.5% concentration) and formocresol (2%, 0.75%, 0.01% and 0.005% concentration). TA98 and TA1535 strain were used in the Ames test to assess mutagenecity. Neither ferric sulfate nor aluminum chloride exhibited mutagenic potential, in comparison with glutaraldehyde and formocresol, which do exhibit mutagenic potential.

LLU Discipline

Pediatric Dentistry

Department

Pediatric Dentistry

School

Graduate School

First Advisor

John E. Peterson

Second Advisor

James D. Kettering

Third Advisor

J. Todd Milledge

Degree Name

Master of Science (MS)

Degree Level

M.S.

Year Degree Awarded

1996

Date (Title Page)

6-1996

Language

English

Library of Congress/MESH Subject Headings

Formocresols -- therapeutic use; Glutaral -- therapeutic use; Mutagens -- therapeutic use; Pulpotomy

Type

Thesis

Page Count

v; 19

Digital Format

PDF

Digital Publisher

Loma Linda University Libraries

Usage Rights

This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights.

Collection

Loma Linda University Electronic Theses and Dissertations

Collection Website

http://scholarsrepository.llu.edu/etd/

Repository

Loma Linda University. Del E. Webb Memorial Library. University Archives

Download

Share

COinS